Verve Therapeutics Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	26.3	27.1	62.66	79.54	3.68	0.11
Depreciation & Amortization	69.66	66.38	41.31	40.02	41.55	-
Other Amortization	0.38	0.38	1.39	-	-	-
Loss (Gain) From Sale of Assets	-13.36	-0.09	-0.05	-0.21	0.11	-
Loss (Gain) on Equity Investments	-	-	-	-	0.01	-0.17
Provision & Write-off of Bad Debts	3.28	9.45	7.84	18.41	1.63	-
Other Operating Activities	33.8	33.74	16.98	0.23	3.12	-
Change in Accounts Receivable	-75.39	-55.82	20.24	-27.64	-40.96	-
Change in Inventory	-84.73	-52.4	-46.02	12.69	-32.91	-
Change in Accounts Payable	66.52	45.43	20.02	-6.54	2.68	-
Change in Other Net Operating Assets	-28.71	0.26	34.9	1.13	139.41	0.06
Operating Cash Flow	-2.24	74.41	159.28	117.63	118.34	0
Operating Cash Flow Growth	-	-53.28%	35.41%	-0.60%	13712237.54%	-
Capital Expenditures	-93.82	-119.19	-191.32	-221.28	-55.54	-
Sale of Property, Plant & Equipment	19.54	0.19	0.08	0.26	-	-
Other Investing Activities	2.75	2.75	-	-	-	-
Investing Cash Flow	-71.53	-116.25	-191.24	-221.02	-55.54	-
Short-Term Debt Issued	-	75.04	-	-	-	-
Long-Term Debt Issued	-	58.29	207.27	257.81	-	-
Total Debt Issued	96.14	133.33	207.27	257.81	-	-
Long-Term Debt Repaid	-	-60.41	-139.44	-159.39	-105.87	-
Net Debt Issued (Repaid)	16.07	72.92	67.83	98.41	-105.87	-
Other Financing Activities	-22.11	-20.69	-14.73	-	-	-
Financing Cash Flow	-6.04	52.23	53.1	98.41	-105.87	-
Net Cash Flow	-79.81	10.39	21.14	-4.98	-43.07	0
Free Cash Flow	-96.06	-44.78	-32.05	-103.66	62.8	0
Free Cash Flow Growth	-	-	-	-	7276785.86%	-
Free Cash Flow Margin	-7.84%	-3.60%	-2.92%	-10.05%	8.61%	-
Free Cash Flow Per Share	-3.20	-1.49	-1.07	-3.46	1255.99	-
Cash Interest Paid	22.11	20.69	14.73	14.01	12.36	-
Levered Free Cash Flow	-121.12	-74.8	-203.53	-135.2	-22.95	-
Unlevered Free Cash Flow	-99.26	-56.14	-194.86	-128.15	-14.59	-
Change in Working Capital	-122.31	-62.54	29.14	-20.36	68.23	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.